Your search returned 870 results.

Results
	41.	The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells. [electronic resource] by de Vries, J F Zwaan, C M De Bie, M Voerman, J S A den Boer, M L van Dongen, J J M van der Velden, V H J Producer: 20120330 In: Leukemia vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	42.	The pan-B cell marker CD22 is expressed on gastrointestinal eosinophils and negatively regulates tissue eosinophilia. [electronic resource] by Wen, Ting Mingler, Melissa K Blanchard, Carine Wahl, Benjamin Pabst, Oliver Rothenberg, Marc E Producer: 20120611 In: Journal of immunology (Baltimore, Md. : 1950) vol. 188 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	Anti-CD22 therapy in acute lymphoblastic leukaemia. [electronic resource] by Hoelzer, Dieter Producer: 20120622 In: The Lancet. Oncology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	44.	High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells. [electronic resource] by Collins, Brian E Blixt, Ola Han, Shoufa Duong, Bao Li, Hongyi Nathan, Jay K Bovin, Nicolai Paulson, James C Producer: 20061005 In: Journal of immunology (Baltimore, Md. : 1950) vol. 177 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	45.	Brain-reactive β-amyloid antibodies in primary CNS angiitis with cerebral amyloid angiopathy. [electronic resource] by Hermann, D M Keyvani, K van de Nes, J Weimar, C Wiltfang, J Nitsch, R M Szodorai, A Producer: 20110930 In: Neurology vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	46.	Targeted therapeutic RNases (ImmunoRNases). [electronic resource] by Schirrmann, Thomas Krauss, Jürgen Arndt, Michaela A E Rybak, Susanna M Dübel, Stefan Producer: 20090113 In: Expert opinion on biological therapy vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	47.	CD22 as a target for cancer therapy. [electronic resource] by Tu, Xiao LaVallee, Theresa Lechleider, Robert Producer: 20120110 In: Journal of experimental therapeutics & oncology vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	48.	CAReful epitope selection matters. [electronic resource] by Handgretinger, Rupert Producer: 20130405 In: Blood vol. 121 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	49.	CD22 binds to alpha-2,6-sialyltransferase-dependent epitopes on COS cells. [electronic resource] by Stamenkovic, I Sgroi, D Aruffo, A Producer: 19920423 In: Cell vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	50.	CD22 regulates time course of both B cell division and antibody response. [electronic resource] by Onodera, Taishi Poe, Jonathan C Tedder, Thomas F Tsubata, Takeshi Producer: 20080310 In: Journal of immunology (Baltimore, Md. : 1950) vol. 180 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	51.	Topics in this issue: cancer testes antigens, immune checkpoints, inflammation associated with ischemia-reperfusion and integrin targeting. [electronic resource] by Bot, Adrian Chiriva-Internati, Maurizio Producer: 20130328 In: International reviews of immunology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	52.	Ribosome display and selection of human anti-cD22 scFvs derived from an acute lymphocytic leukemia patient. [electronic resource] by Rothe, Achim Nathanielsz, Anne Oberhäuser, Frank von Pogge, Strandmann Elke Engert, Andreas Hudson, Peter J Power, Barbara E Producer: 20080923 In: Biological chemistry vol. 389 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	53.	Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy. [electronic resource] by Hardman, Clayton Ho, Stephen Shimizu, Akira Luu-Nguyen, Quang Sloane, Jack L Soliman, Mohamed S A Marsden, Matthew D Zack, Jerome A Wender, Paul A Producer: 20200804 In: Nature communications vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	54.	[Neu5Gc repression in germinal center B cells]. [electronic resource] by Naito, Yuko Takematsu, Hiromu Kozutsumi, Yasunori Producer: 20110103 In: Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme vol. 53 Availability: No items available. Save to lists Add to cart (remove)
	55.	Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions. [electronic resource] by Alborzian Deh Sheikh, Amin Akatsu, Chizuru Imamura, Akihiro Abdu-Allah, Hajjaj H M Takematsu, Hiromu Ando, Hiromune Ishida, Hideharu Tsubata, Takeshi Producer: 20171227 In: Biochemical and biophysical research communications vol. 495 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	56.	Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia. [electronic resource] by Choudhry, A O'Brien, S M Producer: 20180416 In: Drugs of today (Barcelona, Spain : 1998) vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	57.	[CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version]. [electronic resource] by Tsubata, T Producer: 20161213 In: Zeitschrift fur Rheumatologie vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	58.	Monoclonal Antibody Drugs for Systemic Lupus Erythematosus. [electronic resource] by Kamenarska, Zornitsa G Hristova, Maria H Vinkov, Anton I Dourmishev, Lyubomir A Producer: 20160505 In: Folia medica vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	59.	Identification and characterization of fully human anti-CD22 monoclonal antibodies. [electronic resource] by Xiao, Xiaodong Ho, Mitchell Zhu, Zhongyu Pastan, Ira Dimitrov, Dimiter S Producer: 20100610 In: mAbs vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	60.	Epratuzumab for the treatment of systemic lupus erythematosus. [electronic resource] by Geh, Daniel Gordon, Caroline Producer: 20190221 In: Expert review of clinical immunology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 870 results.